Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06726590 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Interprofessional Pharmacogenomics (IPGx) Registry and Repository

Study acronym: IPGx Registry
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Jan 2025 to Nov 2025
    • Site contact updated
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Texas A&M University
34 trials monitored
See 5 trials at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
COPD
1,119 trials monitored
See 34 trials at risk
This program collects genetic and health information to help doctors choose the right medications for patients.
Trial Details
NCT Number NCT06726590
Lead Sponsor Texas A&M University
Conditions
(from sponsor)		 Diabetes, Cholesterol, Cancer, Blood Pressure Disorders, Heart Disease, Respiratory Ilness, COPD, Adverse Drug Reaction (ADR) +1 more
Related terms Diabetes Mellitus, Drug-Related Side Effects and Adverse Reactions, Heart Diseases, Neoplasms, Pulmonary Disease, Chronic Obstructive
Enrollment 3,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov